Page last updated: 2024-11-07

2-acetylaminofluorene and Hemangiosarcoma

2-acetylaminofluorene has been researched along with Hemangiosarcoma in 2 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Hemangiosarcoma: A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Storer, RD1
Cartwright, ME1
Cook, WO1
Soper, KA1
Nichols, WW1
Kroes, R1
Berkvens, JM1
Weisburger, JH1

Other Studies

2 other studies available for 2-acetylaminofluorene and Hemangiosarcoma

ArticleYear
Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM transgenic mice.
    Carcinogenesis, 1995, Volume: 16, Issue:2

    Topics: 2-Acetylaminofluorene; Animals; Benzene; Biotransformation; Body Weight; Carcinogenicity Tests; Carc

1995
Immunosuppression in primary liver and colon tumor induction with N-hydroxy-N-2-fluorenylacetamide and azoxymethane.
    Cancer research, 1975, Volume: 35, Issue:10

    Topics: 2-Acetylaminofluorene; Animals; Antilymphocyte Serum; Azoxymethane; Colonic Neoplasms; Hemangiosarco

1975